These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11292479)

  • 1. Targeting antigen-specific receptors on B lymphocytes to generate high yields of specific monoclonal antibodies directed against biologically active lower antigenic peptides within presenilin 1.
    Tomita M; Sugi H; Ozawa K; Tsong TY; Yoshimura T
    J Immunol Methods; 2001 May; 251(1-2):31-43. PubMed ID: 11292479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell receptor-based multitargeting method for simultaneous production of novel multiple monoclonal antibodies.
    Obata H; Tsumoto K; Tomita M
    J Biosci Bioeng; 2019 Nov; 128(5):578-584. PubMed ID: 31147218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of stereospecific targeting technique for selective production of monoclonal antibodies against native ephrin type-A receptor 2.
    Yamasaki Y; Miyamae C; Isozaki Y; Ichikawa K; Kaneko Y; Oda Y; Murayama T; Sakurai T; Tamai K; Tsumoto K; Tomita M
    J Immunol Methods; 2020; 484-485():112813. PubMed ID: 32592774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies.
    Diehlmann A; Ida N; Weggen S; Grünberg J; Haass C; Masters CL; Bayer TA; Beyreuther K
    J Neurosci Res; 1999 May; 56(4):405-19. PubMed ID: 10340748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
    Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
    Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells.
    Tomita M; Tsong TY
    Biochim Biophys Acta; 1990 Dec; 1055(3):199-206. PubMed ID: 2265207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple overlapping epitopes in the three antigenic regions of horse cytochrome c1.
    Jemmerson R
    J Immunol; 1987 Jan; 138(1):213-9. PubMed ID: 2431055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced hybridoma technology for selective production of high-affinity monoclonal antibodies through B-cell receptors.
    Sakashita K; Tsumoto K; Tomita M
    J Immunol Methods; 2022 Dec; 511():113384. PubMed ID: 36372268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
    Casten LA; Pierce SK
    J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
    Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
    Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Production with Synthetic Peptides.
    Lee BS; Huang JS; Jayathilaka LP; Lee J; Gupta S
    Methods Mol Biol; 2016; 1474():25-47. PubMed ID: 27515072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic activity of antigen receptors artificially incorporated onto B lymphocytes.
    Peacock JS; Londo TR; Roess DA; Barisas BG
    J Immunol; 1986 Sep; 137(6):1916-23. PubMed ID: 2427584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation.
    Davis FM; Gossett LA; Chang TW
    Biotechnology (N Y); 1991 Jan; 9(1):53-6. PubMed ID: 1370037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
    López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
    Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.
    Ozaki S; Berzofsky JA
    J Immunol; 1987 Jun; 138(12):4133-42. PubMed ID: 2438335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species.
    Kivi G; Teesalu K; Parik J; Kontkar E; Ustav M; Noodla L; Ustav M; Männik A
    BMC Biotechnol; 2016 Jan; 16():2. PubMed ID: 26747451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.